This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saile, B. Articles by Ramadori, G. Search for Related Content PubMed PubMed Citation Articles by Saile, B. Articles by Ramadori, G.

American Journal of Pathology, Vol 151, 1265-1272, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair

B Saile, T Knittel, N Matthes, P Schott and G Ramadori
University of Gottingen, Department of Internal Medicine, Germany.

During liver tissue repair, hepatic stellate cells (HSC), a pericyte- like mesenchymal liver cell population, transform from a "quiescent" status ("resting" HSC) into myofibroblast-like cells ("activated" HSC) with the latter representing the principle matrix synthesizing cell of the liver. Presently, the mechanisms that terminate HSC cell proliferation when tissue repair is concluded are poorly understood. Controlled cell death known as apoptosis could be a mechanism underlying this phenomenon. Therefore, apoptosis and its regulation were studied in HSC using an in vitro and in vivo approach. Spontaneous apoptosis became detectable in parallel with HSC activation because resting cells (2 days after isolation) displayed no sign of apoptosis, whereas apoptosis was present in 8% (+/- 5%) of "transitional" cells (day 4) and in 18% (+/- 8%) of fully activated cells (day 7). Both CD95 (APO-1/Fas) and CD95L (APO-1-/Fas-ligand) became increasingly expressed during the course of activation. Apoptosis could be fully blocked by CD95-blocking antibodies in normal cells and HSC already entering the apoptotic cycle. Using CD95-activating antibodies, transition of more than 95% cells into apoptosis was evident at each activation step. The apoptosis-regulating proteins Bcl-2 and p53 could not be detected in resting cells but were found in increasing amounts at days 4 and 7 of cultivation. Whereas p53 expression was induced by the CD95-activating antibody, no change was inducible in Bcl-2 expression. The Bcl-2- related protein bax could be found at days 2 and 4 in similar expression, was considerably up-regulated at day 7, but was not regulated by CD95-agonistic antibodies. In vivo, acute tissue damage was first accompanied by activation and proliferation of HSC displaying no sign of apoptosis. In the recovery phase, apoptotic HSC were detectable in parallel to a reduction in the total number of HSC present in the liver tissue. The data demonstrate that apoptosis becomes detectable in parallel with HSC activation, which suggests that apoptosis might represent an important mechanism terminating proliferation of activated HSC.

This article has been cited by other articles:

				S. V. Siegmund, T. Qian, S. de Minicis, J. Harvey-White, G. Kunos, K. Y. Vinod, B. Hungund, and R. F. Schwabe The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species FASEB J, September 1, 2007; 21(11): 2798 - 2806. [Abstract] [Full Text] [PDF]

				E Novo, F Marra, E Zamara, L Valfre di Bonzo, L Monitillo, S Cannito, I Petrai, A Mazzocca, A Bonacchi, R S M De Franco, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans Gut, August 1, 2006; 55(8): 1174 - 1182. [Abstract] [Full Text] [PDF]

				W.-H. Kim, K. Matsumoto, K. Bessho, and T. Nakamura Growth Inhibition and Apoptosis in Liver Myofibroblasts Promoted by Hepatocyte Growth Factor Leads to Resolution from Liver Cirrhosis Am. J. Pathol., April 1, 2005; 166(4): 1017 - 1028. [Abstract] [Full Text] [PDF]

				S Sanz, J B Pucilowska, S Liu, C M Rodriguez-Ortigosa, P K Lund, D A Brenner, C R Fuller, J G Simmons, A Pardo, M-L Martinez-Chantar, et al. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury Gut, January 1, 2005; 54(1): 134 - 141. [Abstract] [Full Text] [PDF]

				B. Santiago, M. Galindo, G. Palao, and J. L. Pablos Intracellular Regulation of Fas-Induced Apoptosis in Human Fibroblasts by Extracellular Factors and Cycloheximide J. Immunol., January 1, 2004; 172(1): 560 - 566. [Abstract] [Full Text] [PDF]

				H. Ikeda, K. Nagashima, M. Yanase, T. Tomiya, M. Arai, Y. Inoue, K. Tejima, T. Nishikawa, M. Omata, S. Kimura, et al. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G880 - G886. [Abstract] [Full Text] [PDF]

				B. Schaefer, A. M. Rivas-Estilla, N. Meraz-Cruz, M. A. Reyes-Romero, Z. H. Hernandez-Nazara, J.-A. Dominguez-Rosales, D. Schuppan, P. Greenwel, and M. Rojkind Reciprocal Modulation of Matrix Metalloproteinase-13 and Type I Collagen Genes in Rat Hepatic Stellate Cells Am. J. Pathol., June 1, 2003; 162(6): 1771 - 1780. [Abstract] [Full Text] [PDF]

				B. Saile, N. Matthes, K. Neubauer, C. Eisenbach, H. El-Armouche, J. Dudas, and G. Ramadori Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G435 - G444. [Abstract] [Full Text] [PDF]

				F. R. Murphy, R. Issa, X. Zhou, S. Ratnarajah, H. Nagase, M. J. P. Arthur, C. Benyon, and J. P. Iredale Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition. IMPLICATIONS FOR REVERSIBILITY OF LIVER FIBROSIS J. Biol. Chem., March 22, 2002; 277(13): 11069 - 11076. [Abstract] [Full Text] [PDF]

				R Issa, E Williams, N Trim, T Kendall, M J P Arthur, J Reichen, R C Benyon, and J P Iredale Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors Gut, April 1, 2001; 48(4): 548 - 557. [Abstract] [Full Text] [PDF]

				R C BENYON and J P IREDALE Is liver fibrosis reversible? Gut, April 1, 2000; 46(4): 443 - 446. [Full Text] [PDF]

				N. Trim, S. Morgan, M. Evans, R. Issa, D. Fine, S. Afford, B. Wilkins, and J. Iredale Hepatic Stellate Cells Express the Low Affinity Nerve Growth Factor Receptor p75 and Undergo Apoptosis in Response to Nerve Growth Factor Stimulation Am. J. Pathol., April 1, 2000; 156(4): 1235 - 1243. [Abstract] [Full Text] [PDF]

				L. Li, J. Tao, J. Davaille, C. Feral, A. Mallat, J. Rieusset, H. Vidal, and S. Lotersztajn 15-Deoxy-Delta 12,14-prostaglandin J2 Induces Apoptosis of Human Hepatic Myofibroblasts. A PATHWAY INVOLVING OXIDATIVE STRESS INDEPENDENTLY OF PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTORS J. Biol. Chem., October 5, 2001; 276(41): 38152 - 38158. [Abstract] [Full Text] [PDF]